Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS)
Recruiting · NCT06340646 · Interventional (participants receive a specific treatment) · Lead sponsor: Washington University School of Medicine
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
The overall goal of the WU-PE-CGS is to build a rigorous, scientific evidence base for approaches that direct engagement of cancer patients and post-treatment cancer survivors as participants in cancer research, and to investigate the impact of directly engaging participants in decisions regarding returning of genomic results on participants' health and satisfaction. Participants in this study will be presented with the choice of types of genomic results to receive, and the Engagement Optimization Unit (EOU) will investigate the impact of this intervention on participant knowledge, expectations of benefit, personal utility, and decisional conflict.
Who can take part
Eligibility criteria (as published)
Where it is running
1 location listed across 1 US state.
- Washington University School of Medicine - St Louis, Missouri, United States